mRNA Vaccines Targeting the Conserved SARS-CoV-2 Fusion Machinery Elicit Cross-Variant and Robust Immunity.

Li J, Li KM, Yu SH, Li MH, Feng XL, Pang W, Zheng YT, Zhang J

Open source

DOI
10.3390/vaccines14090831
Published
2026 Sep 21
Container
Vaccines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines14090831,
  title = {mRNA Vaccines Targeting the Conserved SARS-CoV-2 Fusion Machinery Elicit Cross-Variant and Robust Immunity.},
  author = {Li J and Li KM and Yu SH and Li MH and Feng XL and Pang W and Zheng YT and Zhang J},
  year = {2026},
  journal = {Vaccines},
  doi = {10.3390/vaccines14090831},
  url = {https://doi.org/10.3390/vaccines14090831}
}

RIS

TY  - JOUR
TI  - mRNA Vaccines Targeting the Conserved SARS-CoV-2 Fusion Machinery Elicit Cross-Variant and Robust Immunity.
AU  - Li J
AU  - Li KM
AU  - Yu SH
AU  - Li MH
AU  - Feng XL
AU  - Pang W
AU  - Zheng YT
AU  - Zhang J
PY  - 2026
JO  - Vaccines
DO  - 10.3390/vaccines14090831
UR  - https://doi.org/10.3390/vaccines14090831
ER  - 

APA

J, L., KM, L., SH, Y., MH, L., XL, F., W, P., YT, Z., & J, Z. (2026). mRNA Vaccines Targeting the Conserved SARS-CoV-2 Fusion Machinery Elicit Cross-Variant and Robust Immunity.. Vaccines. https://doi.org/10.3390/vaccines14090831

Source records